What are the outcomes of thrombectomy for Middle Cerebral Artery (MCA) thrombus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Outcomes of Thrombectomy for MCA Thrombus

Mechanical thrombectomy for MCA occlusion achieves functional independence (mRS 0-2) in approximately 59% of patients, with successful recanalization rates of 81%, though outcomes vary significantly based on occlusion location (M1 vs M2) and baseline stroke severity. 1

Functional Outcomes

Overall Success Rates

  • Functional independence (mRS 0-2) at 90 days occurs in 59% of patients with M2 segment occlusions treated with modern thrombectomy devices 1
  • Good functional outcome (mRS 0-2) is achieved in approximately 36-41% of patients with M1 occlusions, depending on the specific device and technique used 2
  • Successful recanalization (defined as mTICI 2b/3) is the technical goal and is achieved in 81% of M2 occlusions, with comparable rates between stent-retriever and aspiration techniques 1

Impact of Recanalization on Outcomes

  • Successful recanalization is strongly associated with favorable outcomes, with an odds ratio of 4.22 for M2 occlusions compared to poor recanalization 1
  • In patients with severe baseline strokes (ASPECTS 0-5), achieving successful reperfusion provides an adjusted odds ratio of 5.53 for favorable outcome and 5.58 for functional independence 3
  • Recanalization rates are comparable between M1 and M2 occlusions, with no significant difference in technical success 1

Mortality Outcomes

  • Overall mortality at 90 days ranges from 16-20% for M2 occlusions 1
  • Mortality is higher (33-34%) in patients with M1 occlusions and those treated with earlier-generation devices 2
  • In patients with severe strokes (ASPECTS 0-5), successful reperfusion reduces mortality with an adjusted odds ratio of 0.18 3
  • Even in patients with ASPECTS 0-4, the mortality-reducing effect of successful reperfusion remains significant (aOR 0.167) 3

Safety and Hemorrhagic Complications

Symptomatic Intracranial Hemorrhage

  • Symptomatic intracranial hemorrhage (sICH) occurs in approximately 10% of patients with M2 occlusions 1
  • For M1 occlusions, sICH rates range from 6-11% depending on the device and technique used 2
  • Successful reperfusion is associated with lower rates of sICH (aOR 0.235) in patients with severe baseline strokes, contrary to concerns about increased hemorrhagic risk 3

Procedural Complications

  • Procedural complications occur in 6-13% of patients, including device malfunctions and thromboembolic events 2
  • The risk of hemorrhagic complications does not increase with successful recanalization, even in patients with large baseline infarcts 3

Comparative Outcomes: Bridging vs Direct Thrombectomy

  • Bridging thrombolysis (IV tPA followed by thrombectomy) achieves better functional outcomes than direct thrombectomy alone, with higher rates of functional independence regardless of IV tPA eligibility 2
  • The bridging approach results in higher successful recanalization rates (mTICI 2b-3) compared to direct thrombectomy 2
  • Mortality at 90 days is lower with bridging therapy, without increasing the risk of symptomatic intracranial hemorrhage 2

Outcomes by Occlusion Location

M1 Segment Occlusions

  • M1 occlusions generally have lower rates of favorable outcomes compared to M2 occlusions 1
  • In patients with M1 occlusions and distance to thrombus <16 mm, combined IV-MT achieves significantly better outcomes than IV thrombolysis alone (7-day NIHSS improvement: 10.9 vs 6.7; 90-day mRS: 2 vs 4) 4

M2 Segment Occlusions

  • M2 thrombectomy is associated with 59% functional independence, though the evidence level is lower (Class IIb recommendation) 5
  • Recanalization rates for M2 occlusions are equivalent to M1 occlusions (OR 1.05), suggesting technical feasibility 1
  • The primary recommendation for M2 thrombectomy applies to a 6-hour time window from symptom onset 5

Special Populations

Elderly Patients

  • Thrombectomy in octogenarians and nonagenarians is technically feasible with acceptable recanalization rates 2
  • Clinical outcomes at 90 days are improved in elderly patients who receive thrombectomy compared to those who do not, though outcomes are worse than in younger patients 2
  • Symptomatic intracranial hemorrhage rates may be higher in elderly patients undergoing thrombectomy 2

Patients with Severe Baseline Strokes (ASPECTS 0-5)

  • In patients with ASPECTS 0-5, favorable outcome (mRS 0-3) occurs in 40.1% of cases, with mortality of 40.9% 3
  • Successful reperfusion remains beneficial in this population without increasing hemorrhagic risk 3

Critical Time Considerations

  • The benefit of thrombectomy declines with time, though the decline may be 2.5-fold less than for IV thrombolysis alone in large vessel occlusions 2
  • For extended time windows (6-24 hours), strict adherence to DAWN or DEFUSE-3 criteria is essential, particularly for M2 occlusions 5
  • IV thrombolysis should not be delayed or withheld while considering thrombectomy, and evaluation of response to IV tPA should not delay catheter angiography 5

Common Pitfalls to Avoid

  • Failing to achieve adequate recanalization (mTICI 2b/3) significantly worsens outcomes, as the association between successful reperfusion and favorable outcomes is strong across all patient subgroups 1, 3
  • Withholding thrombectomy from patients with large baseline infarcts (ASPECTS 0-5) may deny them the mortality-reducing benefits of successful reperfusion 3
  • Bypassing IV thrombolysis in eligible patients reduces the likelihood of successful recanalization and favorable outcomes 2
  • In patients with M1 occlusions and short distance to thrombus (<16 mm), relying on IV thrombolysis alone results in significantly worse outcomes than combined therapy 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.